News

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...
The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...
Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria. The Research ...
There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar ...
Fortune 500 medical technology firm Stryker (NYSE: SYK), based in Kalamazoo, Michigan, has acquired Durham-based HyperBranch Medical Technology, Inc., for $220 million. HyperBranch CEO Jeff Clark has ...
This practical, one-hour virtual session is designed to help North Carolina life sciences companies understand the basic steps of obtaining CE Mark certification. Regulatory experts from North ...
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health has announced new small business funding opportunities through the Small Business Innovation ...
Corteva Agriscience, a spinout from Dow/Dupont with two North Carolina locations, said its new seed rebranding will help it serve its customers better. The company, which launched as a separate entity ...
Bryn Pharma, a privately held Raleigh medical device company, is on track to soon provide people who have severe, possibly life-threatening allergies a needle-free option to treat anaphylaxis. The U.S ...
Cambrex Corp., a contract manufacturer of small-molecule therapeutics with a growing facility in High Point, has signed an agreement to acquire Avista Pharma Solutions, a contract development, ...